[Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
D000284:Administration, Oral; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects*; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004912:Erythrocytes / Q000201:enzymology; D006168:Guinea Pigs; D000882:Haplorhini; D006321:Heart / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents; D010100:Oxygen
Zur Pharmakologie von 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine), BAY a 1040.